Shire Google Finance
Shire (Now Part of Takeda) on Google Finance
While Shire as an independent company no longer exists, its historical stock market data and information are still accessible through Google Finance. Shire was a global biotechnology company focused on developing and marketing therapies for rare diseases, neuroscience, gastrointestinal, and internal medicine. In 2019, it was acquired by Takeda Pharmaceutical Company Limited.
On Google Finance, you can find Shire's (NASDAQ: SHPG) stock price history, including daily opens, highs, lows, and closing prices. You can also access volume data, indicating the number of shares traded each day. Historical charts are available, allowing you to visualize the stock's performance over different time periods - days, weeks, months, years, and even its entire trading history as a publicly listed company.
To find this information on Google Finance, search for "Shire" or its former ticker symbol "SHPG." You'll be directed to a page that displays the historical data. While real-time price updates ceased after the acquisition, the historical data remains a valuable resource for investors, analysts, and researchers.
Why is this historical data useful?
- Trend Analysis: The data allows you to analyze historical trends in Shire's stock price, helping you understand how the market valued the company over time and in response to specific events.
- Comparative Analysis: You can compare Shire's performance to other biotechnology companies or the broader market indices to gain insights into its relative strengths and weaknesses.
- Research Purposes: Researchers and academics can use the historical data for various studies related to stock market behavior, mergers and acquisitions, and the impact of news events on stock prices.
- Valuation Analysis (Retrospective): Understanding Shire's historical valuation metrics, such as price-to-earnings ratio and price-to-sales ratio, can provide context for evaluating similar companies today.
It's important to remember that the stock data reflects Shire as an independent entity. Post-acquisition, Shire's value is now incorporated into Takeda's stock (NYSE: TAK). Therefore, if you are interested in the combined entity's performance, you should focus on Takeda's stock information on Google Finance.
While Shire's journey as an independent publicly traded company has concluded, its legacy remains. The historical data on Google Finance provides a valuable snapshot of its performance and contributions to the biotechnology industry.